111 (YI) Income from Non-Controlling Interests (2017 - 2025)
111's (YI) quarterly Income from Non-Controlling Interests came in at $30000.0 in Q4 2025, down 97.52% year-on-year from $1.2 million in Q4 2024, and down 90.26% quarter-over-quarter from $308000.0 in Q3 2025.
111 (YI) Income from Non-Controlling Interests (2017 - 2025) Analysis & Trends
111 has disclosed Income from Non-Controlling Interests across 9 years of filings, most recently posting $30000.0 for Q4 2025.
- Income from Non-Controlling Interests for Q4 2025 came in at $30000.0, down 97.52% year-over-year; the trailing twelve-month figure through Dec 2025 was $571000.0 (down 50.56% YoY), and the FY2025 annual result was -$585000.0, up 49.17% from the prior year.
- Income from Non-Controlling Interests came in at $30000.0 for Q4 2025 at 111, down from $308000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $3.9 million in Q2 2021 to a low of -$152000.0 in Q2 2024.
- The 5-year median for Income from Non-Controlling Interests is $509000.0 (2022), against an average of $780000.0.
- Across the five-year window, Income from Non-Controlling Interests surged 7818.37% in 2021 and slumped 151.88% in 2024, its largest moves.
- 111's Income from Non-Controlling Interests stood at $712000.0 in 2021, then retreated by 23.03% to $548000.0 in 2022, then jumped by 131.02% to $1.3 million in 2023, then dropped by 4.42% to $1.2 million in 2024, then tumbled by 97.52% to $30000.0 in 2025.
- The last three Income from Non-Controlling Interests figures came in at $30000.0 (Q4 2025), $308000.0 (Q3 2025), and -$7000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 173.00 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | -11.80 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -19.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 5.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | - |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 30,000.00 |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | - |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | 308,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Mar 31, 2025 | 240,000.00 |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 121,000.00 |
| Jun 30, 2024 | -152,000.00 |
| Mar 31, 2024 | -24,000.00 |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | 591,000.00 |
| Jun 30, 2023 | 293,000.00 |
| Mar 31, 2023 | 204,000.00 |
| Dec 31, 2022 | 548,000.00 |
| Sep 30, 2022 | 497,000.00 |
| Jun 30, 2022 | 521,000.00 |
| Mar 31, 2022 | 706,000.00 |
| Dec 31, 2021 | 712,000.00 |
| Sep 30, 2021 | 1.17 Mn |
| Jun 30, 2021 | 3.88 Mn |
| Mar 31, 2021 | 3.49 Mn |